Substance | <15 | 15–19 | 20–24 | 25–29 | 30–34 | 35–39 | 40–44 | 45+ | Age known | Age not known |
---|---|---|---|---|---|---|---|---|---|---|
Opioids | 1.9 | 7.4 | 30.4 | 48.0 | 57.4 | 63.0 | 66.2 | 64.1 | 172449 | 231 |
Cocaine | 0.9 | 4.8 | 13.5 | 17.9 | 19.8 | 19.1 | 17.2 | 15.5 | 56847 | 75 |
Stimulants | 3.0 | 6.3 | 7.5 | 6.1 | 4.3 | 3.2 | 2.7 | 2.2 | 17151 | 32 |
Hypnotics and sedatives | 0.5 | 0.9 | 1.5 | 1.5 | 1.7 | 2.1 | 2.4 | 6.5 | 7747 | 18 |
Hallucinogens | 0.1 | 0.6 | 0.6 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 958 | 0 |
Volatile substances | 4.2 | 0.7 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 775 | 2 |
Cannabis | 87.4 | 77.9 | 45.0 | 25.0 | 15.4 | 11.5 | 10.2 | 9.5 | 98854 | 163 |
Other substances | 2.1 | 1.4 | 1.4 | 1.2 | 1.1 | 1.0 | 1.1 | 2.0 | 4681 | 12 |
Total | 3947 | 38108 | 56181 | 67046 | 66611 | 51748 | 38485 | 37336 | 359462 | 533 |
The number of treatment clients in each country is listed in Table TDI-7.
See also Table TDI-103 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page.
Reitox national reports 2012 — Table TDI outpatient and inpatient treatment centres.